Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoballoon Ablation vs Anti-arrhythmic Drugs for Persistent Atrial Fibrillation
NCT04942834Completed
- Sponsor
- Ruijin Hospital
- Start
- Oct 2021
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Treatment success at 12 months. Started Oct 2021; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04942834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04942834.